Michael Reardon

facebook_page
twitter_page

Last quote by Michael Reardon

I believe this will lead to rapid approval by the FDA for CoreValve and Evolut in intermediate-risk patients.
Mar 17 2017
Michael Reardon has most recently been quoted in an article called Medtronic heart valve replacement succeeds in intermediate-risk patients: study | Reuters. Michael Reardon said, “We found exceedingly low mortality at one and two years, which should give us great confidence as we move into lower risk (patients)”. Michael Reardon has been quoted a grand total of 3 times in 1 article.
Automatically powered byStoryzy

Quotes by Michael Reardon

<
facebook_page
twitter_page
This webpage has been created by a robot: errors and absent quotes cannot be totally avoided